In the clinical sphere, genomic sequencing is becoming a vital tool for the diagnosis of rare pediatric disorders and the management of oncology. Whole Exome Sequencing (WES) allows clinicians to pinpoint the exact genetic driver of a disease, ending "diagnostic odysseys" for families who have spent years seeking answers. In oncology, liquid biopsies—which sequence circulating tumor DNA from a simple blood draw—are being used to monitor treatment response and detect recurrence much earlier than traditional imaging. This move toward precision medicine ensures that therapies are tailored to the individual's genetic makeup.
5 Views
